Intravenous adenosine alleviates neuropathic pain: A double blind placebo controlled crossover trial using an enriched enrolment design

Pain

Volumn 103, Issue 1-2, 2003, Pages 111-117

  Lynch, Mary Elizabeth ^a   Clark, Alexander John ^a   Sawynok, Jana ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Clinical trial; Enriched enrolment; Intravenous adenosine; Neuropathic pain

Indexed keywords

ADENOSINE; PLACEBO;

ALLODYNIA; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSPNEA; FLUSHING; HEADACHE; HUMAN; HYPERALGESIA; MAJOR CLINICAL STUDY; NAUSEA; NEUROPATHIC PAIN; OPEN STUDY; PAIN ASSESSMENT; PARESTHESIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUESTIONNAIRE; SCALE UP; SIDE EFFECT; SWEATING; TASTE DISORDER; THORAX PAIN; TREATMENT OUTCOME; VERTIGO;

EID: 0038243600     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(02)00419-0     Document Type: Article

References (36)

1. Aley K.O., Green P.G., Levine J.D. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal. J Neurosci. 15:1995;8031-8038.
2. 1 antinociception, tolerance, and withdrawal. J Neurosci. 17:1997;735-744.
3. Belfrage M., Sollevi A., Segerdahl M., Sjolund K., Hansson P. Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain. Anesth Analg. 81:1995;713-717.
4. Byas-Smith M.G., Max M.B., Muir J., Kingman A. Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched enrollment' design. Pain. 60:1995;267-274.
5. 2 receptors of the substantia gelatinosa are located predominantly on intrinsic neurons: an autoradiography study. J Pharmacol Exp Ther. 247:1988;757-764.
6. Cronstein B.N. Adenosine and its receptors during inflammation. Serhan C.N., Ward P.A. Molecular and cellular basis of inflammation. 1998;259-274 Humana Press, Totawa, NJ.
7. Deuchars S.A., Brooke R.E., Deuchars J. Adenosine A1 receptors reduce release from excitatory but not inhibitory synaptic inputs onto lateral horn neurons. J Neurosci. 21:2001;6308-6320.
8. Dickenson A.H., Suzuki R., Reeve A.J. Adenosine as a potential analgesic target in inflammatory and neuropathic pains. CNS Drugs. 13:2000;77-85.
9. Dixon A.K., Gubitz A.K., Sirinathsinghji D.J.S., Richardson P.J., Freeman T.C. Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol. 18:1996;1461-1468.
10. 1 receptor-mediated excitation of nociceptive afferents innervating the normal and arthritic rat knee joint. Br J Pharmacol. 125:1998;1267-1271.
11. Dunwiddie T.V., Masino S.A. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci. 24:2001;31-55.
12. Ekblom A., Segerdahl M., Sollevi A. Adenosine but not ketamine or morphine increases cutaneous heat pain threshold in healthy volunteers. Acta Anaesthesiol Scand. 39:1995;717-722.
13. Esquisatto L.C.M., Costa S.K.P., Camargo E.A., Ribela M.T.C.P., Brain S.D., de Nucci G., Antunes E. The plasma protein extravasation induced by adenosine and its analogues in the rat dorsal skin: evidence for the involvement of capsaicin sensitive afferent neurones and mast cells. Br J Pharmacol. 134:2001;108-115.
14. Galer B.S., Jenson M.P. The neuropathy pain scale. Neurology. 48:1997;332-338.
15. 1 receptors. J Am Coll Cardiol. 25:1995;251-257.
16. Geiger J.D., LaBella F.S., Nagy J.I. Characterization and localization of adenosine receptors in rat spinal cord. J Neurosci. 4:1984;2303-2310.
17. Gyllenhammar E., Nordfors L.O. Systemic adenosine infusions alleviated neuropathic pain. Pain. 94:2001;121-122.
18. Karlston R., Gordh T. An A1-selective adenosine agonist abolishes allodynia elicited by vibration and touch after intrathecal injection. Anesth Analg. 80:1995;844-847.
19. Lao L.J., Kumamoto E., Luo C., Furue H., Yoshimura M. Adenosine inhibits excitatory transmission to substantia gelatinosa neurons of the adult rat spinal cord through the activation of presynaptic A1 adenosine receptor. Pain. 94:2001;315-324.
20. Liu X.J., White T.D., Sawynok J. Enhanced release of adenosine in rat hind paw following spinal nerve ligation: involvement of capsaicin-sensitive sensory afferents. Neuroscience. 114:2002;379-387.
21. Melzack R. The McGill pain questionnaire. Pain. 30:1987;191-197.
22. Patel M.K., Pinnock R.D., Lee K. Adenosine exerts multiple effects in dorsal horn neurones of the adult rat spinal cord. Brain Res. 920:2001;19-26.
23. Rane K., Segerdahl M., Goiny M., Sollevi A. Intrathecal adenosine administration, a phase 1 clinical safety study in healthy volunteers, with additional evaluation of its influence on sensory thresholds and experimental pain. Anesthesiology. 89:1998;1108-1115.
24. Reppert S.M., Weaver D.R., Stehle J.H., Rivkees S.A. Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord. Mol Endocrinol. 5:1991;1037-1048.
25. Sawynok J. Adenosine receptor activation and nociception. Pain. 347:1998;1-11.
26. Sawynok J. Purines in pain management. Curr Opin CPNS Invest Drugs. 1:1999;27-38.
27. Segerdahl M., Ekblom A., Sollevi A. The influence of adenosine, ketamine and morphine on experimentally induced ischemic pain in healthy volunteers. Anesth Analg. 79:1994;787-791.
28. Segerdahl M., Ekblom A., Sjolund K.F. Systemic adenosine attenuates touch evoked allodynia induced by mustard oil in humans. NeuroReport. 6:1995;753-756.
29. Segerdahl M., Ekblom A., Sandelin K., Wickman M., Sollevi A. Preoperative adenosine infusion reduces the requirements for isoflurane and postoperative analgesics. Anesth Analg. 80:1995;1145-1149.
30. Segerdahl M., Persson E., Ekblom A., Sollevi A. Perioperative adenosine infusion reduces isoflurane requirements during general anesthesia for shoulder surgery. Acta Anaesthesiol Scand. 40:1996;792-797.
31. Segerdahl M., Irestedt L., Sollevi A. Antinociceptive effect of perioperative adenosine infusion in hysterectomy. Acta Anaesthesiol Scand. 41:1997;473-479.
32. Segerdahl M., Sollevi A. Adenosine and pain relief: a clinical overview. Drug Dev Res. 45:1998;151-158.
33. Sjolund KF, Segerdahl M, Sollevi A. Adenosine reduces secondary hyperalgesia in two human models of cutaneous inflammatory pain. Experimental and clinical studies on adenosine receptor stimulation in cutaneous hypersensitivity and neuropathic pain. Section IV. Karolinska Institute, Stockholm, 1998.
34. Sjolund K.F., Segerdahl M., Sollevi A. Adenosine reduces secondary hyperalgesia in two human models of cutaneous inflammatory pain. Anesth Analg. 88:1999;605-610.
35. Sollevi A., Belfrage M., Lundeberg T., Segerdahl M., Hansen P. Systemic adenosine infusion: a new treatment modality to alleviate neuropathic pain. Pain. 61:1995;155-158.
36. Zarate E., Sá Rêgo M., White P.F., Duffy L., Shearer V.E., Griffin J.D., Whitten C.W. Comparison of adenosine and remifentanil infusions as adjuvants to desflurane anesthesia. Anesthesiology. 90:1999;956-963.